ASRA LAST im Vergleich zu MHApp - Malignant Hyperthermia Nutzung und Statistiken

The ASRA LAST app facilitates the use of the ASRA Checklist for Treatment of Local Anesthetic Systemic Toxicity during real time patient events or simulation training. Not only do we focus on the dosing and timing of lipid emulsion for a LAST event, but we ensure that providers don’t forget critical ACLS steps as they are integrated into this modified treatment algorithm. This app was built with collaboration from the ASRA Board and Dr. Guy Weinberg, the pioneer and expert in lipid emulsion treatment for local anesthetic toxicity and director of LipidRescue. • The app provides step by step instructions and reminders for key events throughout the algorithm. • Weight based calculations for drug dosing throughout the app. • Cyclically timed reminders for Pulse Recheck, CPR, drug dosing, and more. • Differential pathways for pulseless and pulsatile toxicity events. • Reminders for seizure management. • In-app quick reference links to the published Checklist, ASRA.com, and LipidRescue. We’ve also included the ability to generate a Report of all the timed events during the use of the app. This report can be saved, printed, or emailed as needed by the user. In addition, we’ve added the ability for the user to voluntarily submit their report with additional demographic information to LipidRescue so that Dr. Guy Weinberg can continue to share individual experiences of this rare event with the world in an effort to improve outcomes. **************************** **************************** No Protected Health Information (PHI) or user identifiable information is submitted in the report. **************************** **************************** Project developed at Vanderbilt University Medical Center. Code written by Mustard Seed Software LLC.

Apple App Store
Bezahlt
Medizin

Rang speichern

- -

MHApp - Malignant Hyperthermia

Finally it’s back! The much appreciated MHApp is finally back in the AppStore. Rewritten from ground up in Swift. A modern user interface. And the best is: it is free of charge! Please note: MHApp is not a substitute for medical advice. MHApp is intended for educational purposes only. The purpose of this app is to use it to train and teach yourself in management of malignant hyperthermia. It might serve as a valuable tool in simulated MH scenarios. Do you know what to do in case of a malignant hyperthermia crisis? Are you sure somebody will take a detailed protocol during your actions? MHApp does both for you: MHApp is like an interactive MH-emercency poster. Simulating an MH crisis and teaching the acute management will certainly be of great value in case of a real crisis. MHApp will guide you through a simulated malignant hyperthermia (MH) crisis. The App includes treatment of acidosis, hyperkalemia and dosing of dantrolene or ryanodex Every action and injected dantrolene doses are recorded in a log file, which can be exported. The clinical grading score (CGS) estimates the probability of an MH episode. The result can be exported as PDF. A section with information about MH, anesthesia for the known MH patients, preparation of anesthesia workstations, MH-mutations and more. This app was developed by international experts in Malignant Hyperthermia: Dr. Henry Rosenberg (President of MHAUS) Prof. Thierry Girard (director of the Swiss MH unit) MHApp is endorsed by the North American MH Group (www.mhaus.org), as well as by the European MH Group (www.emhg.org). Programmed by Thierry Girard, Girard Development GmbH DISCLAIMER: The application MHApp is not a substitute for medical advice. MHApp is intended for educational purposes only. While the data may be updated periodically, users should independently check medical literature and package inserts or other sources for the latest information. Any and all liability arising directly or indirectly from the use of this application is hereby disclaimed. The information herein is provided "as is" and without any warranty expressed or implied. All direct, indirect, special, incidental, consequential or punitive damages arising from any use of this application or data contained herein is disclaimed and excluded.